$2.89
3.21% yesterday
NYSE, Nov 25, 10:01 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Stock price

$2.89
+0.68 30.77% 1M
-0.19 6.17% 6M
+1.38 91.39% YTD
+1.62 127.56% 1Y
-4.86 62.71% 3Y
-7.11 71.10% 5Y
-7.11 71.10% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.09 3.21%
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Key metrics

Market capitalization $975.57m
Enterprise Value $437.62m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 202.60
P/S ratio (TTM) P/S ratio 451.65
P/B ratio (TTM) P/B ratio 1.93
Revenue (TTM) Revenue $2.16m
EBIT (operating result TTM) EBIT $-134.45m
Free Cash Flow (TTM) Free Cash Flow $-99.33m
Cash position $549.14m
EPS (TTM) EPS $-2.17
P/E forward negative
P/S forward 480.01
EV/Sales forward 215.32
Short interest 4.72%
Show more

Is Nuvation Bio Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Nuvation Bio Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Nuvation Bio Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2.16 2.16
-
100%
- Direct Costs 3.38 3.38
1,308% 1,308%
156%
-1.22 -1.22
408% 408%
-56%
- Selling and Administrative Expenses 48 48
58% 58%
2,201%
- Research and Development Expense 85 85
17% 17%
3,943%
-134 -134
30% 30%
-6,200%
- Depreciation and Amortization 0.52 0.52
117% 117%
24%
EBIT (Operating Income) EBIT -134 -134
30% 30%
-6,224%
Net Profit -532 -532
542% 542%
-24,643%

In millions USD.

Don't miss a Thing! We will send you all news about Nuvation Bio Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuvation Bio Inc - Ordinary Shares - Class A Stock News

Neutral
Business Wire
14 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, will present at the Jefferies London Healthcare Conference in London, U.K., on Tuesday, November 19, 2024, at 3:30 a.m. ET/...
Neutral
Business Wire
20 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today reported financial results for the third quarter ended September 30, 2024, and provided a business update. David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, reflected on the quarter and st...
Neutral
Business Wire
about 2 months ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced the appointment of Philippe Sauvage as Chief Financial Officer (CFO). Mr. Sauvage brings over 20 years of global leadership experience in finance, operations, and commercialization within healthcare and biopharm...
More Nuvation Bio Inc - Ordinary Shares - Class A News

Company Profile

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Head office United States
CEO David Hung
Employees 51
Founded 2018
Website www.nuvationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today